COMMUNIQUÉS West-GlobeNewswire

MMI Raises $125M in Series D to Accelerate Commercial Growth of the Symani Surgical System Worldwide
08/10/2026
Financing will support market expansion, expand access, and advance the clinical evidence needed to broaden the role of robotic microsurgery JACKSONVILLE, Fla., Oct. 08, 2026 (GLOBE NEWSWIRE) -- MMI (Medical [...]
Amneal to Report Third Quarter 2026 Results on November 3, 2026
08/10/2026
BRIDGEWATER, N.J., Oct. 08, 2026 (GLOBE NEWSWIRE) -- Amneal Pharmaceuticals, Inc. (NASDAQ: AMRX) (“Amneal” or the “Company”), today announced it will report third quarter 2026 financial results on Tuesday, November 3, [...]
Aardvark Therapeutics Appoints Clinical Development Leader David Zhang, Ph.D., MBA, to its Board of Directors
08/10/2026
Brings more than 25 years of experience in clinical strategy, biostatistics and regulatory submissions from Abivax, Alumis, MyoKardia and Genentech/Roche SAN DIEGO, Oct. 08, 2026 (GLOBE NEWSWIRE) -- Aardvark [...]
TOMI Environmental Solutions, Inc. Reports Preliminary Third Quarter 2026 Revenue of $2.5 Million, Up 27% Year-Over-Year
08/10/2026
Recognized sales and the full open order book together total $9 million; $1.7 million booked for the fourth quarter FREDERICK, Md., Oct. 08, 2026 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc. (NASDAQ: TOMZ), a [...]
CRISPR Therapeutics to Present Late-Breaking Data at the American Heart Association (AHA) Scientific Sessions 2026
08/10/2026
ZUG, Switzerland and BOSTON, Oct. 08, 2026 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP) today announced that clinical data from the Phase 1b trial of CTX310 ® , its investigational CRISPR/Cas9 in vivo gene [...]
CytoDyn to Present Updated Data from Phase 2 CLOVER Clinical Study at ESMO Congress 2026
08/10/2026
VANCOUVER, Washington, Oct. 08, 2026 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTCQB: CYDY) (“CytoDyn” or the “Company”), a clinical-stage oncology company advancing leronlimab, a first-in-class humanized monoclonal antibody [...]
Nexalin Technology Regains Compliance with Nasdaq Minimum Bid Price Requirement; Nasdaq Hearings Panel Grants Request for Continued Listing
08/10/2026
Company remains focused on its transition toward commercial revenue generation and the advancement of its U.S. clinical programs HOUSTON, Oct. 08, 2026 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (Nasdaq: NXL) (the “ [...]
Retrieve Medical Announces National Distribution Agreement for Retrieve Passport
08/10/2026
Agreement with a leading U.S. financial services and membership platform establishes a major new consumer distribution channel. BEDMINSTER, N.J., Oct. 08, 2026 (GLOBE NEWSWIRE) -- Retrieve Medical Holdings, Inc. (OTC: [...]
SRX Global Commits $2.5 Million to Launch Multi-Strategy Trading Platform in Partnership with 5T Trading, Powered by the EMJX Platform
08/10/2026
New platform to be launched with managers from Millennium Management, Balyasny and Citadel, designed to enable the next generation of proprietary traders under Eric Jackson’s leadership NORTH PALM BEACH, Fla., Oct. 08, [...]
Vaxart Announces Publication of Preclinical Study Demonstrating 100% Protection Against a Lethal Dose of H5N1 Avian Flu in a Ferret Challenge Model
08/10/2026
Second-generation oral mucosal vaccine candidate (VXA-H5-02) induced robust cross-neutralizing antibodies, significantly reduced viral load, and completely protected against lethal clade 2.3.4.4b viral challenge SOUTH [...]
IMUNON to Participate in Upcoming Investor Conferences
08/10/2026
LAWRENCEVILLE, N.J., Oct. 08, 2026 (GLOBE NEWSWIRE) -- IMUNON, Inc. (Nasdaq: IMNN), a clinical-stage biotechnology company developing DNA-mediated immunotherapies, today announced that Stacy Lindborg, Ph.D., President [...]
Myriad Genetics and SOPHiA GENETICS Announce New Collaboration to Advance Prostate Genomic Instability Score Technology
08/10/2026
SALT LAKE CITY and BOSTON, Oct. 08, 2026 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. , (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine and SOPHiA GENETICS (NASDAQ: SOPH) today announce a [...]
Privia Health to Report Third Quarter 2026 Results on Thursday, November 5
08/10/2026
ARLINGTON, Va., Oct. 08, 2026 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) today announced that it expects to release financial results for its third-quarter and nine-month periods ended September 30, [...]
Precision Neuroscience Unveils a New Map of the Human Nervous System
08/10/2026
A uniquely large dataset spanning cortex, brainstem, and spinal cord in 70 patients—released as the Precision system passes its 100th patient implant NEW YORK, Oct. 08, 2026 (GLOBE NEWSWIRE) -- Precision Neuroscience [...]
Femasys to Exhibit at the ASRM 2026 Scientific Congress & Expo
08/10/2026
Continued participation underscores commitment to expanding options for patients referred to fertility centers under the care of reproductive endocrinologists ATLANTA, Oct. 08, 2026 (GLOBE NEWSWIRE) -- Femasys Inc. ( [...]
Solera Health Launches Cancer Care Network to Connect Members to Digital Cancer Screening, Supportive Care and Treatment Navigation
08/10/2026
Network pairs Iris by OncoHealth® and Fuze Health to support members across their journey, from early detection through care navigation PHOENIX, Oct. 08, 2026 (GLOBE NEWSWIRE) -- Solera Health , the premier digital [...]
Fieldstone Bio Selected for Rio Tinto and Founders Factory Mining Tech Accelerator
08/10/2026
Investment marks Fieldstone's first backing from the mining industry WOBURN, Mass., Oct. 08, 2026 (GLOBE NEWSWIRE) -- Fieldstone Bio , a synthetic biology company building a new class of critical-mineral biosensors, [...]
Daré Bioscience to Present Phase 1 Sildenafil Cream Data at Sexual Medicine Society of North America (SMSNA) Annual Fall Scientific Meeting
08/10/2026
Medical Director Annie Thurman, MD, FACOG to present adverse event and relative bioavailability data comparing topical Sildenafil Cream with oral sildenafil in healthy male adults SAN DIEGO, Oct. 08, 2026 (GLOBE [...]
Biofrontera Submits Supplemental New Drug Application to FDA to Expand Ameluz® Red Light PDT to Actinic Keratoses on the Full Body
08/10/2026
Submission seeks to extend the Ameluz ® label beyond the face and scalp to treatment fields of up to approximately 240 cm² on the rest of the body, with an adjusted illumination protocol WOBURN, Mass., Oct. 08, 2026 ( [...]

Pages